EE433 A US Claims Database Analysis of the Impact of Fremanezumab on Migraine-Related Health Care Utilization and Costs in Patients with Common Comorbidities, Acute Medication Overuse, or Difficult-to-Treat Migraine
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.681
https://www.valueinhealthjournal.com/article/S1098-3015(22)00882-8/fulltext
Title :
EE433 A US Claims Database Analysis of the Impact of Fremanezumab on Migraine-Related Health Care Utilization and Costs in Patients with Common Comorbidities, Acute Medication Overuse, or Difficult-to-Treat Migraine
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00882-8&doi=10.1016/j.jval.2022.04.681
First page :
Section Title :
Open access? :
No
Section Order :
10610